Hoffman William's Form 4 filing
Inari Medical, Inc.NARI · filed Apr 7, 2022
- Accession no.
- 0001562180-22-003323
- Filed
- Apr 7, 2022, 4:34 PM ET
- Trade date
- Apr 5, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.71M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2022 | Common Stock | MOption exerciseAcquired | +30,000 | $0.428 | +$12,840 | 580,307 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −2,771 | $88.78F2 | −$246,009.38 | 577,536 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −7,149 | $89.77F3 | −$641,765.73 | 570,387 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −20,080 | $90.63F4 | −$1,819,850.4 | 550,307 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2022 | Common Stock | MOption exerciseDisposed | −30,000 | $0.428 | −$12,840 | 140,467 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $88.20 to $89.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $89.22 to $90.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $90.22 to $91.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.